Johnson & Johnson has signed a definitive agreement for the acquisition of Halda Therapeutics (Halda) in a deal valued at ...

Merus and Halozyme have signed a worldwide non-exclusive partnership and licence agreement for subcutaneous formulation of ...

A CHMP panel has recommended the high-dose version’s approval, countering an FDA rejection for the drug in recent months.

The FDA’s verdict on Poherdy comes amid Perjeta creator Genentech’s patent infringement lawsuit against Organon and Shanghai ...

Medicxi will use the €500m kitty to continue supporting drug hunters and entrepreneurs in creating asset-focused ...